DK1267892T3 - Anvendelse af CDP-cholin til behandling af alkoholabstinenssyndrom - Google Patents

Anvendelse af CDP-cholin til behandling af alkoholabstinenssyndrom

Info

Publication number
DK1267892T3
DK1267892T3 DK01936147T DK01936147T DK1267892T3 DK 1267892 T3 DK1267892 T3 DK 1267892T3 DK 01936147 T DK01936147 T DK 01936147T DK 01936147 T DK01936147 T DK 01936147T DK 1267892 T3 DK1267892 T3 DK 1267892T3
Authority
DK
Denmark
Prior art keywords
treatment
alcohol withdrawal
withdrawal syndrome
choline
cdp
Prior art date
Application number
DK01936147T
Other languages
English (en)
Inventor
Rafael Foguet
Jorge Ramentol
Jesus Torres
Rafael Lozano
Julian Agut
Manuel M Raga
Josep M Castell
Jose A Ortiz
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Application granted granted Critical
Publication of DK1267892T3 publication Critical patent/DK1267892T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
DK01936147T 2000-03-29 2001-03-28 Anvendelse af CDP-cholin til behandling af alkoholabstinenssyndrom DK1267892T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200000765A ES2170649B1 (es) 2000-03-29 2000-03-29 Uso de la cdp-colina en el tratamiento de la abstinencia alcoholica.
PCT/EP2001/003536 WO2001072288A2 (en) 2000-03-29 2001-03-28 Use of cdp-choline for the treatment of alcohol withdrawal syndrome

Publications (1)

Publication Number Publication Date
DK1267892T3 true DK1267892T3 (da) 2005-03-07

Family

ID=8492914

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01936147T DK1267892T3 (da) 2000-03-29 2001-03-28 Anvendelse af CDP-cholin til behandling af alkoholabstinenssyndrom

Country Status (21)

Country Link
US (1) US6894032B2 (da)
EP (1) EP1267892B1 (da)
JP (1) JP4724348B2 (da)
KR (1) KR100794891B1 (da)
AT (1) ATE281172T1 (da)
AU (2) AU6214101A (da)
BR (1) BR0109477A (da)
CA (1) CA2402707C (da)
CZ (1) CZ298933B6 (da)
DE (1) DE60106890T2 (da)
DK (1) DK1267892T3 (da)
ES (1) ES2170649B1 (da)
IL (2) IL151163A0 (da)
MX (1) MXPA02009442A (da)
NO (1) NO329766B1 (da)
NZ (1) NZ520825A (da)
PL (1) PL199291B1 (da)
PT (1) PT1267892E (da)
RU (1) RU2251422C2 (da)
WO (1) WO2001072288A2 (da)
ZA (1) ZA200206349B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001068104A1 (en) 2000-03-16 2001-09-20 The Mclean Hospital Corporation Compounds for the treatment of psychiatric or substance abuse disorders
CA2492725A1 (en) * 2002-07-11 2004-01-22 Yamasa Corporation Medicinal composition for drug-induced neuropathy
PT1565055E (pt) 2002-11-08 2013-09-16 Mclean Hospital Corp Compostos para o tratamento da dependência e da privação de tabaco
WO2004058160A2 (en) * 2002-12-20 2004-07-15 The Mclean Hospital Corporation Compounds for the normalization of the sleep/wake cycle
JP2007508315A (ja) * 2003-10-08 2007-04-05 ザ マクレーン ホスピタル コーポレーション ω−３脂肪酸を含む組み合わせを用いて、精神障害、物質乱用障害、および他の障害を治療する方法
WO2005122767A1 (en) 2004-06-10 2005-12-29 Mclean Hospital Corporation Pyrimidines, such as uridine, in treatments for patients with bipolar disorder
US7947661B2 (en) 2004-08-11 2011-05-24 The Mclean Hospital Corporation Compounds for the treatment of marihuana dependence, withdrawal, and usage

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308627A (en) * 1990-08-07 1994-05-03 Umbdenstock Jr Anthony J Nutritional supplement for optimizing cellular health
RU2072239C1 (ru) * 1991-01-11 1997-01-27 Институт биохимии СО РАМН Способ коррекции метаболической зависимости от алкоголя и средство л.е.панина для его осуществления
DE4342173A1 (de) * 1993-12-10 1995-06-14 Lohmann Therapie Syst Lts Pharmazeutische Formulierung zur Prophylaxe bzw. Vorbehandlung einer Vergiftung durch phosphororganische Cholinesterasehemmer
CN101066276A (zh) * 1994-07-01 2007-11-07 威尔斯塔特医疗公司 用于治疗全身性炎症和炎性肝炎的嘧啶核苷酸前体
RU2127589C1 (ru) * 1997-06-03 1999-03-20 Порембский Ярослав Олегович Способ лечения стрессорных поражений нервной системы
KR100217488B1 (ko) * 1997-06-03 1999-09-01 맹섭 골프채의 헤드커버
US5958896A (en) * 1997-08-08 1999-09-28 The Mclean Hospital Cytidine-containing and cytosine-containing compounds as treatments for stimulant exposure
WO2001068104A1 (en) * 2000-03-16 2001-09-20 The Mclean Hospital Corporation Compounds for the treatment of psychiatric or substance abuse disorders

Also Published As

Publication number Publication date
KR20030005248A (ko) 2003-01-17
NO20024574L (no) 2002-11-22
ATE281172T1 (de) 2004-11-15
IL151163A0 (en) 2003-04-10
AU2001262141B2 (en) 2005-03-10
AU6214101A (en) 2001-10-08
DE60106890T2 (de) 2005-11-03
MXPA02009442A (es) 2003-02-12
ES2170649B1 (es) 2003-06-16
RU2251422C2 (ru) 2005-05-10
BR0109477A (pt) 2003-06-03
NO20024574D0 (no) 2002-09-24
WO2001072288A2 (en) 2001-10-04
NO329766B1 (no) 2010-12-13
CZ20023245A3 (cs) 2003-03-12
EP1267892A2 (en) 2003-01-02
ZA200206349B (en) 2003-08-08
PL199291B1 (pl) 2008-09-30
ES2170649A1 (es) 2002-08-01
KR100794891B1 (ko) 2008-01-14
EP1267892B1 (en) 2004-11-03
NZ520825A (en) 2004-04-30
RU2002129579A (ru) 2004-03-27
DE60106890D1 (de) 2004-12-09
CA2402707A1 (en) 2001-10-04
PT1267892E (pt) 2005-03-31
IL151163A (en) 2011-01-31
PL363177A1 (en) 2004-11-15
US6894032B2 (en) 2005-05-17
JP2003528133A (ja) 2003-09-24
JP4724348B2 (ja) 2011-07-13
CZ298933B6 (cs) 2008-03-12
WO2001072288A3 (en) 2002-05-10
US20030162749A1 (en) 2003-08-28
CA2402707C (en) 2007-11-13

Similar Documents

Publication Publication Date Title
BR0015188A (pt) Composições farmacêuticas
ECSP11005768A (es) Derivados de azol-pirimidina condensados
BR0213358A (pt) Uso de flibanserina
AR035927A1 (es) Compuesto de lactama (n)-((s)-2-hidroxi-3-metilbutiril)-1-(l-alaninil)-(s)-1-amino-3-metil-4,5,6,7-tetrahidro-2h-3-benzazepin-2-ona , composicion farmaceutica que lo comprende, procedimiento para la inhibicion de la liberacion de peptido b-amiloide y/o su sintesis que lo emplea y su uso para la fabr
BR0108893A (pt) Composição farmacêutica, composto e processo de preparação de compostos
PT102548A (pt) Formulacao farmaceutica para administracao por injeccao do composto 7alfa-¬9-(4,4,5,5,5-pentafluoropentilsulfinil)-nonil| estra-1,3,5(10)-trieno-3,17beta-diol (fulvestrant)
NO20025601D0 (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
AR030829A1 (es) Una formulacion de vacuna, procedimiento para la produccion de la misma, uso de dicha preparacion y un estuche para su administracion via intranasal
NO20023551D0 (no) Ibuprofen-inneholdende aktivt middel-preparat
NO20025635L (no) Anvendelse av biguanidderivater til fremstilling av et legemiddel som har en sarhelende virkning
BR0113590A (pt) 7-oxo-piridopirimidinas
SE0102440D0 (sv) New compound
GEP20053617B (en) Bridged Piperazine Derivatives
ATE360428T1 (de) Analgetisches arzneimittel
DK1150704T3 (da) Melagatran til behandling af betændelse
NO20024574L (no) Anvendelse av CDP-kolin for behandling av alkoholabstinens
NO20031410L (no) Anvendelse av distamycinderivater for fremstilling av medikamenter
AP1530A (en) Pharmaceutical composition for intramuscular injection containing loxoprofen.
BR0107160A (pt) Uso de um éter cìclico para o preparo de medicamentos que afetam a tolerância à glicose
ES2179526T3 (es) Analogos y profarmacos del paclitaxel solubles en agua.
ECSP003551A (es) Complejo farmaceutico
BR0112690A (pt) Medicamento contendo cilansetron para o tratamento de pacientes ibs masculinos não-obstipativos
DK1399141T3 (da) Anvendelse af acetyl L-carnitin til fremstilling af et lægemiddel til forebyggende terapi af post-kirurgisk smerte
BR0213463A (pt) Composições farmacêuticas contendo macrólidos
DK1399143T3 (da) Anvendelsen af Acetyl L-carnitin til fremstilling af et lægemiddel til behandling af anhedoni